These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 35953863)

  • 21. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
    Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
    Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer management: strategies in drug delivery.
    Singh P; Waghambare P; Khan TA; Omri A
    Expert Opin Drug Deliv; 2022 Jun; 19(6):653-670. PubMed ID: 35656670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy.
    Xu X; Wu Y; Qian X; Wang Y; Wang J; Li J; Li Y; Zhang Z
    Adv Healthc Mater; 2022 Jan; 11(1):e2101428. PubMed ID: 34706400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
    van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
    Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer.
    Akbarzadeh Khiavi M; Safary A; Barar J; Ajoolabady A; Somi MH; Omidi Y
    Cell Mol Life Sci; 2020 Mar; 77(6):997-1019. PubMed ID: 31563999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Niosomes as a Promising Therapeutic Approach against Colorectal Cancer: A Focus on the Delivery of Chemotherapeutics and Natural Products.
    Mollazadeh S; Al-Asady AM; Barjasteh A; Latifi H; Avan A; Khazaei M; Ryzhikov M; Hassanian SM
    Curr Pharm Des; 2024; 30(21):1659-1666. PubMed ID: 38747232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panitumumab-Conjugated Pt-Drug Nanomedicine for Enhanced Efficacy of Combination Targeted Chemotherapy against Colorectal Cancer.
    Tsai MH; Pan CH; Peng CL; Shieh MJ
    Adv Healthc Mater; 2017 Jul; 6(13):. PubMed ID: 28418176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer.
    Marabada D; Li J; Wei S; Huang Q; Wang Z
    Chem Biol Drug Des; 2023 Dec; 102(6):1618-1631. PubMed ID: 37705133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
    Zhang Y; Ho SH; Li B; Nie G; Li S
    Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.
    Ceelen W; Ramsay RG; Narasimhan V; Heriot AG; De Wever O
    Trends Cancer; 2020 Mar; 6(3):236-246. PubMed ID: 32101726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel nanomedicines to overcome cancer multidrug resistance.
    Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
    Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging frontiers in nanomedicine targeted therapy for prostate cancer.
    Adekiya TA; Owoseni O
    Cancer Treat Res Commun; 2023; 37():100778. PubMed ID: 37992539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
    Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
    Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
    Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.